p38
-
C9127 TRi-1Summary: A selective irreversible TXNRD1 inhibitor for redox biology research. -
C9081 BI-3406Summary: A KRASSOS1 inhibitor for RAS pathway research, with nanomolar in vitro activity. -
C4675 AcenocoumarolSummary: A potent vitamin K epoxide reductase (VKOR) inhibitor and vitamin K antagonist. -
C5850 SD 1692 CitationSummary: selective ATP competitive inhibitor of the MAP kinases p38α and p38β -
C5316 RWJ 676572 CitationSummary: orally active inhibitor of the MAP kinases p38α and p38β -
B7850 BMS-582949 hydrochlorideSummary: p38 MAPK inhibitor -
C4949 SB 202474Summary: a negative control in studies of p38 inhibition -
B6188 Pamapimod (R-1503, Ro4402257)Summary: p38 MAPK inhibitor -
B6187 BMS-582949Summary: p38 MAPK inhibitor -
B6012 Pexmetinib (ARRY-614)2 CitationTarget: p38|Tie-2Summary: dual inhibitor of p38 MAPK and Tie2/Tek receptor tyrosine kinase
